Discuss the impact of cannabis use on your GLP-1 therapy or diagnosed gastroparesis with your care team
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2 4 mg for weight management: a randomised, controlled, phase 1b trial
The FDA issued a warning letter on March 5 to Novo Nordisk after inspectors found the company had failed to properly report serious adverse events associated with Ozempic and Wegovy
A $50 million settlement may sound impressive, but if it represented compensation divided among 500 clients, individual recoveries averaged only $100,000 potentially inadequate for cases involving permanent gastroparesis requiring lifetime medical treatment
Heres just how powerful this effect is: 37% of a solid meal remained in the stomach four hours after eating (compared to 0% in the placebo group!) in patients who had been on semaglutide for 12 weeks
Our guides on storing peptides after reconstitution and general peptide storage cover best practices in detail